Quality of orthodontic treatment with straightwire or standard edgewise appliances
| ISRCTN | ISRCTN13048456 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN13048456 |
| Secondary identifying numbers | ABOZUROSL |
- Submission date
- 09/04/2018
- Registration date
- 29/05/2018
- Last edited
- 29/05/2018
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Oral Health
Plain English summary of protocol
Background and study aims
The type of orthodontic appliance (brace) used might have a direct effect on the results and duration of treatment. This study aims to compare two kinds of braces (one pre-programmed and one not) from treated patients' records to assess any differences in the quality of treatment.
Who can participate?
Patients treated with fixed orthodontic appliances (braces) for crooked teeth
What does the study involve?
The study involves assessing routinely-collected anonymized treatment records (stone cast models and x-rays of the teeth) taken before insertion of the orthodontic appliances and directly after their removal (around 18-60 months later).
What are the possible benefits and risks of participating?
All patients have been already treated in the two participating university clinics to have their teeth straightened and before treatment they have signed an informed consent form that their anonymized data can be used for research purposes. No additional risks are imposed on the patients other than risks that are normally included in the average treatment with dental braces. The benefits to be gained are in the form of increased treatment effectiveness with one of the two brace types, which is translated to patients being burdened for less time during treatment by the braces and the subsequent reduction of side effects.
Where is the study run from?
1. University of Zurich (Switzerland)
2. University of Oslo (Norway)
When is the study starting and how long is it expected to run for?
March 2017 to September 2018
Who is funding the study?
University of Zurich (Switzerland)
Who is the main contact?
Dr Spyridon Papageorgiou
snpapage@gmail.com
Contact information
Public
Clinic of Orthodontics and Pediatric Dentistry
Center of Dental Medicine
University of Zurich
Plattenstrasse 11
Zurich
CH-8032
Switzerland
 ORCID ID |
0000-0003-1968-3326 |
|---|---|
| Phone | +41 (0)44 634 32 87 |
| snpapage@gmail.com |
Study information
| Study design | Retrospective non-randomized comparative multi-center observational cohort study |
|---|---|
| Primary study design | Observational |
| Secondary study design | Cohort study |
| Study setting(s) | Hospital |
| Study type | Treatment |
| Participant information sheet | Not available in web format, please use the contact details to request a patient information sheet |
| Scientific title | Clinical outcomes of orthodontic extraction treatment with pre-adjusted versus standard edgewise appliances: a retrospective cohort study |
| Study objectives | There is no difference in the occlusal outcome of comprehensive orthodontic extraction treatment, as measured with the American Board of Orthodontics (ABO) Objective Grading System (OGS), with either pre-adjusted edgewise appliances and standard edgewise appliances. |
| Ethics approval(s) | 1. Regional Committees for Medical and Health Research Ethics, 26/10/2017, ref: 2017/1885 2. Kantonale Ethikkommission Zürich, ID: 2018-00631 - approval pending |
| Health condition(s) or problem(s) studied | Most orthodontic malocclusions can be effectively treated with comprehensive fixed appliance treatment, due to the ability of the latter to perform controlled tooth movements in all three planes of space. Often, severe arch length discrepancies or several dental/skeletal malocclusions necessitate the incorporation of dental extractions in the orthodontic treatment plan. |
| Intervention | Patient clinical documentation is consistently taken by all orthodontists both before insertion of the orthodontic appliances and directly after their removal (around 18-60 months after insertion). This documentation consists of intraoral/extraoral photographs, impressions made with metal trays and alginate to construct dental cast models of the patient’s dentition, and radiographs. These documentation, including each patient’s written log of treatment will be used as material for this study. |
| Intervention type | Device |
| Pharmaceutical study type(s) | |
| Phase | |
| Drug / device / biological / vaccine name(s) | |
| Primary outcome measure | The ABO OGS score will be evaluated using all its 8 components: alignment, marginal ridges, buccolingual inclination, overjet, occlusal contacts, occlusal relationships, interproximal contacts, and root angulation. This is measured from the patients’ post-treatment documentation (stone cast models of the occlusion and x-ray) using a specific checklist/form provided by ABO. The overall cumulative score for all ABO OGS categories will be used as primary outcome. The principal investigator (S.N.P.) has prior to initiation of the study completed the necessary calibration process as instructed by the ABO. All measurements will be obtained using the special ABO gauge provided with the calibration kit. The principal investigator has extensive experience in cephalometric analyses and their assessment for research purposes. The primary outcome of this study will be the overall ABO OGS score in a continuous scale (expected to be normally-distributed). Reliability of the method Descriptive and inferential statistics will be performed to detect both random and systematic errors of the method. Initially, Dahlberg's formula will be used to assess intra examiner repeatability. With the aid of a table of random numbers, 10 patients will be randomly selected and will be re-evaluated 10 days later by the same examiner (S.N.P.) and also by a second examiner. Next, the intraclass correlation coefficient and the Bland-Altman limits of agreement [Bland and Altman, 1986] will be used to evaluate interexaminer agreement. |
| Secondary outcome measures | The secondary outcomes will include each of the separate components of the ABO OGS score that is used as a summary in the primary outcome. Additionally, the treatment duration will be also extracted from the patient files and be used together with the ABO OGS to assess treatment efficacy. As treatment durations are expected to differ between the two centers, we might consider normalizing treatment durations within each center with the average duration of each center. |
| Overall study start date | 01/03/2017 |
| Completion date | 01/09/2018 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | All |
| Sex | Both |
| Target number of participants | A priori sample size calculation has been performed for the primary outcome of ABO OGS based on the previous study of Mislik et al. 2016 (PMID 26827982) using: (i) control mean of 25.7 points, (ii) standard deviation of 8.7 points - assumed common between groups, (iii) a clinically meaningful difference in ABO OGS of 30% of the control mean, (iv) use of an unpaired Student’s t-test, (v) alpha of 5%, and (vi) beta of 20%. With these baseline data and assumptions, a needed sample of 22 patients/group (to a total of 44 patients) was calculated. In order to account for patient losses due to eventually excluded radiographs/models this was rounded up to 25 patients/group (to a total of 50 patients). |
| Key inclusion criteria | 1. Any ethnicity or race 2. Male or female 3. Class I, Class II, or Class III malocclusion 4. Full complement of teeth excluding the third molars 5. No previous orthodontic treatment 6. No dentofacial deformities or clefts 7. Complete set of diagnostic records With the following treatment characteristics to control for factors that might influence treatment outcome or duration: 1. One phase treatment with labial fixed appliances in both arches (no two-phase treatment) 2. Bilateral extraction of a premolar in one or two jaws (either 2- or 4-premolars extracted) 3. No temporary anchorage devices of any form 4. No orthognathic surgery 5. No dental trauma 6. No impacted canines 7. Complete set of treatment records |
| Key exclusion criteria | Does not meet inclusion criteria |
| Date of first enrolment | 01/05/2018 |
| Date of final enrolment | 01/08/2018 |
Locations
Countries of recruitment
- Norway
- Switzerland
Study participating centres
8032
Switzerland
0455
Norway
Sponsor information
University/education
Plattenstrasse 11
Zurich
8032
Switzerland
| Website | http://www.zzm.uzh.ch/de.html |
|---|---|
"ROR" |
https://ror.org/02crff812 |
Funders
Funder type
University/education
Government organisation / Universities (academic only)
- Alternative name(s)
- University of Zurich, Switzerland, University of Zurich, UZH
- Location
- Switzerland
Results and Publications
| Intention to publish date | 01/09/2019 |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Stored in repository |
| Publication and dissemination plan | The study’s protocol, including the Statistical Analysis Plan will be made openly available following ethical approval and prior to study initiation through the Open Science Framework (https://osf.io/). After study completion a scientific paper will be performed and submitted to a leading scientific journal in the field of dentistry/orthodontics. A list of general dental and orthodontic journals according to submission preference has been made a priori. Additionally, the results of the study will be disseminated through social media and be formally presented in international scientific congresses (like the congress of the European Orthodontic Society in 2019). |
| IPD sharing plan | After study conduct, submission, and acceptance of the paper from a scientific journal, the anonymized dataset of the study will be made openly available through the Zenodo repository (https://zenodo.org/). |
